BioLargo, Inc. (BLGO)
OTCMKTS · Delayed Price · Currency is USD
0.1681
+0.0082 (5.13%)
Oct 13, 2025, 4:00 PM EDT
BioLargo Revenue
BioLargo had revenue of $2.78M in the quarter ending June 30, 2025, a decrease of -44.62%. This brings the company's revenue in the last twelve months to $14.05M, down -16.43% year-over-year. In the year 2024, BioLargo had annual revenue of $17.78M with 45.37% growth.
Revenue (ttm)
14.05M
Revenue Growth
-16.43%
P/S Ratio
3.53
Revenue / Employee
334.57K
Employees
44
Market Cap
49.61M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 17.78M | 5.55M | 45.37% |
Dec 31, 2023 | 12.23M | 6.35M | 107.85% |
Dec 31, 2022 | 5.88M | 3.35M | 132.48% |
Dec 31, 2021 | 2.53M | 99.00K | 4.07% |
Dec 31, 2020 | 2.43M | 571.00K | 30.68% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
The Monarch Cement Company | 252.15M |
Panamera Holdings | 212.04K |
Premier Development & Investment | 1.10M |
Rubber Leaf | 2.02M |
Cardinal Ethanol, LLC | 350.34M |
Xtra Energy | 559.33K |
BioLargo News
- 18 hours ago - BioLargo Subsidiary Clyra Medical Accelerates Toward Near-Term Product Launches and Global Expansion - Accesswire
- 6 days ago - BioLargo Protects Its Intellectual Property That Built a National Brand - Pooph's License Was Revoked for Non-Payment and Unauthorized Activities - Accesswire
- 14 days ago - BioLargo Demonstrates Over 99% Removal of Ultrashort-Chain PFAS Including TFA Using Aqueous Electrostatic Concentration Technology - Accesswire
- 17 days ago - BioLargo to Showcase Breakthrough PFAS Solutions at WEFTEC 2025, Booth #6009 - Accesswire
- 18 days ago - BioLargo Protects its Intellectual Property, Revokes Pooph License Due to Failure to Pay and Other Contract Breaches - Accesswire
- 2 months ago - BioLargo Reports Q2 2025 Operating and Financial Results - Accesswire
- 2 months ago - BioLargo Q2 2025 Earnings Results Webcast and Conference Call on Friday, August 15, 2025 - 11 AM Eastern Time - Accesswire
- 2 months ago - BioLargo Provides Review of 2025 Accomplishments and Insights for Coming Year - Accesswire